Schedule 13G ownership disclosure

OnKure Therapeutics, Inc.

Class A Common Stock, par value $0.0001 per share · CUSIP: 68277Q105

Event date: 2025-11-24

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Prosight Management, LP

    Shares: 745,649.00 · Class: 5.8%

  • Prosight Fund, LP

    Shares: 35,514.00 · Class: 0.3%

  • Prosight Plus Fund, LP

    Shares: 163,487.00 · Class: 1.3%

  • Prosight Partners, LLC

    Shares: 745,649.00 · Class: 5.8%

  • W. Lawrence Hawkins

    Shares: 745,649.00 · Class: 5.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-116660
Form type
SCHEDULE 13G
Filer
OnKure Therapeutics, Inc.
CIK
CIK 1637715
Filed
Nov 28, 2025
Reporting period
Nov 24, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub